Researchers Optimistic about Genomics Funding, Rate Illumina and Life Tech Best in Class

A survey jointly conducted by GenomeWeb and Mizuho Securities also found that Illumina and Life Technologies are expected to collect the biggest bounty from any increase in NIH funding.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.